Proteomics refers to the study of the entire set of proteins that are expressed by a particular organism or a tissue. It plays an important role in drug discovery, diagnostics, and personalized medicine. The global proteomics market is expected to grow significantly in the coming years due to increasing demand for personalized medicine and advancements in proteomics technologies. This report analyzes the global proteomics market size, share, and trends, focusing on instrumentation technology, application, region, and segment forecasts for the period 2021-2028.
Instrumentation Technology:
The instrumentation technology segment of the global proteomics market is divided into spectroscopy, chromatography, electrophoresis, and X-ray crystallography. Among these, chromatography is expected to hold the largest share in the market due to its high sensitivity, selectivity, and accuracy. It is widely used in proteomics for separation and purification of proteins. In addition, advancements in chromatography technology have led to the development of new and improved techniques such as liquid chromatography-mass spectrometry (LC-MS), which is highly sensitive and efficient in protein separation and analysis.
Spectroscopy is also expected to grow significantly due to its ability to provide structural information about proteins. The increasing demand for structural proteomics is expected to drive the growth of this segment. Electrophoresis and X-ray crystallography are also expected to witness steady growth in the coming years.
Application:
The application segment of the global proteomics market is divided into drug discovery, clinical diagnosis, agriculture, and others. Drug discovery is expected to hold the largest share in the market due to the increasing demand for personalized medicine and the need for better and more efficient drug development. Proteomics plays an important role in drug discovery by identifying potential drug targets, understanding drug mechanisms of action, and assessing drug efficacy and safety.
Clinical diagnosis is also expected to grow significantly due to the increasing demand for accurate and efficient diagnostic tests. Proteomics-based diagnostic tests have the potential to improve the accuracy and efficiency of diagnosis, especially for complex diseases such as cancer and Alzheimer’s disease. Agriculture is expected to witness steady growth in the coming years due to the increasing demand for high-quality and high-yielding crops. Proteomics can help in the development of new and improved crop varieties by identifying important proteins involved in plant growth, development, and stress response.
Region:
The global proteomics market is divided into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America is expected to hold the largest share in the market due to the presence of well-established healthcare infrastructure, increasing government funding for research and development, and the presence of major proteomics companies in the region.
Europe is also expected to grow significantly due to the increasing focus on personalized medicine and advancements in proteomics technologies. Asia Pacific is expected to witness the fastest growth in the coming years due to the increasing demand for proteomics-based diagnostic tests and drug discovery, and the presence of a large patient pool in the region.
Segment Forecasts:
The global proteomics market is segmented by instrumentation technology, application, and region. By instrumentation technology, the market is segmented into spectroscopy, chromatography, electrophoresis, and X-ray crystallography. By application, the market is segmented into drug discovery, clinical diagnosis, agriculture, and others. By region, the market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
The chromatography segment is expected to hold the largest share in the market due to its high sensitivity, selectivity, and accuracy. The drug discovery segment is expected to hold the largest share in the market by application due to the increasing demand for personalized medicine and the need for better and more efficient drug development.
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Everest Market Insights journalist was involved in the writing and production of this article.
